Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
If Mounjaro is suitable, your treatment will be sent to you and you will gain access to our exclusive weight loss support materials
Lilly releases Zepbound (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Image INDIANAPOLIS- Eli Lilly and Company (NYSE: LLY) today announced Zepbound (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly expanding the supply of Zepbound in response to high demand
According to Mounjaros prescribing information, the drug also contains: Sodium chloride: This ingredient helps to make injections less painful, maintains the stability of the medication, and prolongs its shelf life
Best fit Maximum weight-loss potential Outcome signal Up to 22.5% mean loss Evidence cue SURMOUNT evidence Decision rhythm Week 1 / Weeks 4-8 / Months 3-6 Best-fit signals Choose Compounded Tirzepatide when these match your goal Maximum weight-loss potential Decision timeline What to expect as you compare Compounded Tirzepatide Timelines vary by goal, dose, baseline health, and consistency
Injection Administration, Side Effects, Contraindications and How to Manage Side Effect s Tirzepatide Injection Sites This is a weekly injection and it is recommended to administer the medication on the same day and ideally the same time each week
